Alfred Sommer:
Risks still outweigh advantages of mass smallpox vaccination
12/26/2002
BALTIMORE
PRESIDENT BUSH has announced plans to allow voluntary vaccination
of all who want it, but some things are worth remembering in
deciding whether to volunteer:
Smallpox is a very nasty disease. The variola major form of the
virus, which affects 90 percent of those who have contracted the
disease, kills a third of its victims.
There is no proven treatment once you are ill with smallpox.
Smallpox generally spreads slowly. In a crowded municipality in
Bangladesh in which I worked in 1972, only 3 percent of inhabitants
became infected, the vast majority before we began vaccine-control
activities.
The risk of our being exposed to smallpox is unknown (and
unknowable).
The virus no longer exists in the wild. Only two countries are
known with certainty to have stores of the virus: the United States
and Russia. We have not been given evidence that other countries or
individuals possess the virus and, if they do, whether they would
attack us.
There are several points worth remembering about the smallpox
vaccine:
It is very nasty. Healthy individuals will develop sore arms and
weeping blisters and will shed virus capable of infecting others.
Anyone with a depressed immune response (from HIV, chemotherapy,
organ transplantation, etc.) or a predilection for skin disorders
such as eczema stands a significant risk of developing the
life-threatening disease, including those who were inadvertently
infected by someone who was recently vaccinated.
The vaccine is highly effective in preventing disease and death
from smallpox, even when administered four to five days after a
person becomes infected. I know, because I conducted one of the
seminal investigations that established this fact.
It makes sense to vaccinate a small core group of public-health,
hospital and other first responders. They will feel safer responding
to potential cases. They can be carefully screened and followed to
minimize complications and secondary spread of the vaccine virus.
Perhaps most importantly, that provides training and tests our plans
and procedures for mass vaccination, should that ever become
necessary.
Given the unknown risk of ever being exposed to smallpox, and the
known risks of complications from vaccination (particularly the
potential for inadvertent spread to those at high risk of
life-threatening disease), one can justify nearly any position
regarding voluntary mass vaccination.
But it would seem to make little sense to risk vaccine
complications in the absence of a known threat so long as effective
plans and procedures are in place for responding to an introduction
of smallpox.
Alfred Sommer is dean of the Johns Hopkins University School of
Public Health.